trial

Extreme Challenges - Psychopathology & Treatment Experiences Among Severly Selfharming Inpatients in Norway

NCTId NCT03768674
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 1,640 (actual)
Sponsored by Oslo University Hospital
Primary completion 2021-09-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
1,640 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2019-10-01
Primary completion
2021-09-01
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Assessment of diagnoses, functioning and health services

Sponsors

Oslo University HospitalLead Sponsor
ExtrastiftelsenCollaborator
National Advisory Unit for Personality Psychiatry (NAPP)Collaborator
Research Group Personality PsychiatryCollaborator
Network for personality-focused treatmentCollaborator
National Centre for Suicide Research and Prevention (NSSF)Collaborator
Regional Centre for Violence and Traumatic Stress (RVTS)Collaborator
Regional Centre for Early Intervention Psychosis (TIPS SØrØst)Collaborator
Regional collaborators and usersCollaborator

Investigators

1
Elfrida H Kvarstein, MD,PhDPrincipal Investigator

Sites

1 total
Oslo, Norway

Facts & assertions

4 sourced
Enrollment
1,640
Phase
NA
Primary Completion Date
2021-09-01
Status
COMPLETED
relationships
The graph out of here
drug
Assessment of diagnoses, functioning and health services
drug
lead_sponsor
Oslo University Hospital
company
collaborator
Extrastiftelsen
company
National Advisory Unit for Personality Psychiatry (NAPP)
company
indication
Self Harm
indication
Self-Injurious Behavior
indication
Personality Disorders
indication
investigator
Elfrida H Kvarstein, MD,PhD
person